These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12804835)

  • 1. Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A/Leningrad/134/17/57.
    Wareing MD; Tannock GA
    Vaccine; 2003 Jul; 21(23):3097-100. PubMed ID: 12804835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.
    Chen KS; Burlington DB; Quinnan GV
    J Virol; 1987 Jul; 61(7):2150-4. PubMed ID: 3586130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice.
    Wareing MD; Watson JM; Brooks MJ; Tannock GA
    J Med Virol; 2001 Sep; 65(1):171-7. PubMed ID: 11505460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
    Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response.
    Minne A; Louahed J; Mehauden S; Baras B; Renauld JC; Vanbever R
    Immunology; 2007 Nov; 122(3):316-25. PubMed ID: 17521369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.
    Liu H; Patil HP; de Vries-Idema J; Wilschut J; Huckriede A
    PLoS One; 2013; 8(7):e69649. PubMed ID: 23936066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Med Virol; 1985 Dec; 17(4):325-35. PubMed ID: 4078559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs.
    Ghazi HO; Potter CW; Smith TL; Jennings R
    J Med Microbiol; 1995 Jan; 42(1):53-61. PubMed ID: 7739026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine.
    Zahradnik JM; Kasel JA; Martin RR; Six HR; Cate TR
    J Med Virol; 1983; 11(4):277-85. PubMed ID: 6875521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.
    Moldoveanu Z; Clements ML; Prince SJ; Murphy BR; Mestecky J
    Vaccine; 1995 Aug; 13(11):1006-12. PubMed ID: 8525683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
    Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
    Vaccine; 1990 Jun; 8(3):243-8. PubMed ID: 2363302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung.
    Proudfoot O; Esparon S; Tang CK; Laurie K; Barr I; Pietersz G
    BMC Infect Dis; 2015 Feb; 15():101. PubMed ID: 25887952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
    Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral influenza vaccination induces a rapid systemic and local immune response.
    Brokstad KA; Cox RJ; Olofsson J; Jonsson R; Haaheim LR
    J Infect Dis; 1995 Jan; 171(1):198-203. PubMed ID: 7798664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H9N2 influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice.
    Qin T; Yin Y; Huang L; Yu Q; Yang Q
    Clin Vaccine Immunol; 2015 Apr; 22(4):421-9. PubMed ID: 25673304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge.
    Plante M; Jones T; Allard F; Torossian K; Gauthier J; St-Félix N; White GL; Lowell GH; Burt DS
    Vaccine; 2001 Oct; 20(1-2):218-25. PubMed ID: 11567767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.